Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
- PMID: 21494579
- PMCID: PMC3073597
- DOI: 10.1016/j.cancergen.2010.12.006
Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
Abstract
Reproducible cytogenetic analysis in CLL has been limited by the inability to obtain reliable metaphase cells for analysis. CpG oligonucleotide and cytokine stimulation have been shown to improve metaphase analysis of CLL cytogenetic abnormalities, but is limited by variability in the cytokine receptor levels, stability and biological activity of the cytokine in culture conditions and high costs associated with these reagents. We report here use of a novel, stable CpG, GNKG168 along with pokeweed mitogen (PWM) and phorbol 12-myristate 13-acetate (PMA) for conventional cytogenetic assessment in CLL. We demonstrate that the combined use of GNKG168+PWM/PMA increased the sensitivity of detection of chromosomal abnormalities compared to PWM/PMA (n=207, odds ratio=2.2, p=0.0002) and GNKG168 (n=219, odds ratio=1.5, p=0.0452). Further, a significant increase in sensitivity to detect complexity ≥3 with GNKG168+PWM/PMA compared to GNKG168 alone (odds ratio 8.0, p=0.0022) or PWM/PMA alone (odds ratio 9.6, p=0.0007) was observed. The trend toward detection of higher complexity was significantly greater with GNKG168+PWM/PMA compared to GNKG168 alone (p=0.0412). The increased sensitivity was mainly attributed to the addition of PWM/PMA with GNKG168 because GNKG168 alone showed no difference in sensitivity for detection of complex abnormalities (p=0.17). Comparison of fluorescence in situ hybridization (FISH) results with karyotypic results showed a high degree of consistency, although some complex karyotypes were present in cases with no adverse FISH abnormality. These studies provide evidence for potential use of GNKG168 in combination with PWM and PMA in karyotypic analysis of CLL patient samples to better identify chromosomal abnormalities for risk stratification.
Figures
Similar articles
-
[Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Feb;27(1):86-91. doi: 10.3760/cma.j.issn.1003-9406.2010.01.019. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010. PMID: 20140876 Chinese.
-
CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells.Br J Haematol. 2002 Sep;118(4):968-75. doi: 10.1046/j.1365-2141.2002.03719.x. Br J Haematol. 2002. PMID: 12199774
-
Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.Genes Chromosomes Cancer. 2009 Oct;48(10):843-53. doi: 10.1002/gcc.20691. Genes Chromosomes Cancer. 2009. PMID: 19582829
-
Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.Leukemia. 1997 Apr;11 Suppl 2:S19-24. Leukemia. 1997. PMID: 9178833 Review.
-
Genetic features of B-cell chronic lymphocytic leukemia.Rev Clin Exp Hematol. 2000 Mar;4(1):48-72. doi: 10.1046/j.1468-0734.2000.00003.x. Rev Clin Exp Hematol. 2000. PMID: 11486330 Review.
Cited by
-
Genomic instability in a chronic lymphocytic leukemia patient with mono-allelic deletion of the DLEU and RB1 genes.Mol Cytogenet. 2019 Jan 31;12:2. doi: 10.1186/s13039-019-0417-5. eCollection 2019. Mol Cytogenet. 2019. PMID: 30733830 Free PMC article.
-
Synergy: karyotypes and mutations in CLL.Blood. 2016 Jul 21;128(3):319-20. doi: 10.1182/blood-2016-06-719898. Blood. 2016. PMID: 27445409 Free PMC article.
-
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia.Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):420-7. doi: 10.1016/j.clml.2015.02.001. Epub 2015 Feb 11. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25800543 Free PMC article.
-
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.Blood. 2019 Mar 14;133(11):1205-1216. doi: 10.1182/blood-2018-09-873083. Epub 2019 Jan 2. Blood. 2019. PMID: 30602617 Free PMC article.
-
Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center.Leukemia. 2014 Jun;28(6):1365-8. doi: 10.1038/leu.2014.42. Epub 2014 Jan 23. Leukemia. 2014. PMID: 24451411 Free PMC article. Clinical Trial. No abstract available.
References
-
- Byrd JC, Stilgenbauer S, Flinn IW. Chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2004:163–83. - PubMed
-
- Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198–206. - PubMed
-
- Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219–34. - PubMed
-
- Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840–7. - PubMed
-
- Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–54. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources